In regulated sectors, approval belongs at the start, not the end
Healthcare campaigns do not fail on the creative, they fail on when review gets to see it. A process that cuts the loop from weeks to days.
In healthcare, pharma and other regulated sectors, campaigns rarely fail because they were badly conceived. They fail because review only gets a say once production is finished.
This is not legal advice and does not replace assessment by a qualified adviser. It only describes how to order the process so that you hit the limits before they cost money.
Why a late loop costs so much
When a finished visual goes for approval, two questions are answered at once: whether the claim holds, and whether it can be changed without rebuilding the concept. The second is more expensive than the first.
Ask the same question over a single page of core claims and you change a sentence. Ask it over a shot film and you change the budget.
What to prepare before the creative
A written schedule of claims. What exactly do we want to say, what supports it, and where that support lives. One page, no design.
First review happens over that document. Only approved claims go into the creative — and the creative may then add nothing that is not on the list. That is the whole trick.
Where it usually goes wrong
In details that appear during production: a headline that shortens an approved sentence until the meaning changes. Subtitles on video. Social captions written by someone other than whoever sat through approval.
Then in reuse. Material approved last year may not hold today, and moving a campaign into another language or onto another platform is a new version, not a copy.
What changes in practice
Approval stops being a brake at the end and becomes a brief at the beginning. The creative gets clearer limits, production is not rebuilt, and deadlines can be promised. Standards do not drop — you simply meet them while a fix still costs an hour’s work.